Stefan Catsicas
Co-Founder and Managing Partner @ Skyviews Life Science
Vevey, Switzerland
Stefan Catsicas is a seed investor at Skyviews Life Science in Vevey focused on Biotechnology and Medical. Prof. Stefan Catsicas has been the Chief Technology Officer and Executive Vice President at Nestlé S.A. since September 1, 2013. Prof. Catsicas is the President and Founder at Tilocor Life Sciences. He was the Vice President at Polytechnique Fédérale de Lausanne. Prof. Catsicas was the Department Head and managed research and preclinical programsin Neurosciences at the Glaxo Institute for Molecular Biology and served as Professor and Chairman of Cellular Biology at the School of Medicine in Lausanne. He was then appointed the Vice-President and Research Director at the Swiss Federal Institute of Technology in Lausanne (EPFL) where he still holds the Chair of Cellular Engineering. In addition to his academic activities Prof. Catsicas has promoted and advised biotechnology companies in Europe and in the United States and has been an Advisor for investment funds such as the Pictet Biotech Fund. He is a Director of Therasis, Inc. and Eclosion SA. Prof. Catsicas received a Ph.D. in Neurosciences from the University of Lausanne and did postdoctoral work at the Research institute of Scripps Clinic.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Stefan Catsicas invests in
Stages Stefan Catsicas invests in
Countries Stefan Catsicas invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Life Science 1 (50%)
- Manufacturing 1 (50%)
- Food and Beverage 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Volumina Medical
|
Volumina is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues (fat, muscles, glandular tissues, supporting and connective tissues) that have been lost after tumor ablation, disease, trauma, or for purely esthetically purposes. | Series A / Oct 04, 2022 | |
MIRAI FOODS
|
Mirai Foods is a cellular agriculture startup developing cultured beef. | $4.5M / Seed / Mar 15, 2021 |
Co-Investors
Clinique La Prairie
1 deal together
PINC
1 deal together
Team Global
1 deal together
Yakumi
1 deal together
About Skyviews Life Science
Skyviews Life Science is a privately held advisory company specializing in personalized health. Skyviews Life Science identifies investment opportunities in companies at the growing interface between biotechnology, advanced nutrition, and digital health.Skyviews Life Science focuses in private and public companies with better drugs, advancedtechnology platforms, preventive strategies, personalized solutions, and more natural foods that will improve people’s quality of life.
Skyviews Life Science Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Boris F. J. Collardi
Founding investor
|
|||
|
Jean-Pierre Aoun
Co-Founder and General Partner
|
|||
R. Anthony Williamson
Partner Biotechnology and Health Science
|
|||
|
Stefan Catsicas
Co-Founder and Managing Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Stefan Catsicas invest in?
Stefan Catsicas invests primarily in Biotechnology, Medical and Life Science startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Stefan Catsicas last invest?
The most recent investment recorded for Stefan Catsicas closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
